Object. Several adverse effects such as brain edema, necrosis, arterial stenosis, hemorrhage after obliteration, and delayed cyst formation have been reported as early and late complications of Gamma Knife surgery (GKS) for arteriovenous malformations (AVMs). These adverse effects seem to be decreased in a lower-dose treatment regimen compared with the classic higher margin doses of 25 Gy because the radiation insult to the surrounding tissue is minimized. Long-term results of lower-dose GKS for AVMs are presented.
S EVERAL AREs such as brain swelling, necrosis, arterial stenosis, hemorrhage after obliteration, and delayed cyst formation have been reported as longterm complications of GKS for AVMs. 1, [6] [7] [8] 11 Most patients who suffered these AREs were treated more than 10 years ago with the classic higher dose radiation of 25 Gy and at a time when MR imaging studies were not available for dose planning. Recent advances in radiosurgical techniques and imaging modalities have changed the way in which dose planning and treatment delivery to vascular lesions and tumors are performed. Recently reported margin doses have tended to be lower than those previously reported, especially in patients with vestibular schwannomas to avoid cranial nerve injury. 2 Although a relationship between margin dose and obliteration rate is obvious in AVM treatment, the complication rate increases with dose escalation, especially in patients with relatively large AVMs. We have reported on the concept of optimal dose treatment for AVMs and shown the Abbreviations used in this paper: ARE = adverse radiation effect; AVM = arteriovenous malformation; CT = computerized tomography; GKS = Gamma Knife surgery; MR = magnetic resonance. efficacy of lower-dose treatment for small to large AVMs. 5 Previously reported complications seem to be decreased with lower-dose treatment because the radiation insult to the surrounding tissue can be minimized.
Analyses of data obtained in patients who underwent a second treatment for residual AVM have shown that the main cause of failure of the initial radiosurgery was the uncertain identification of AVM nidi, even when using MR imaging during the procedure. 9 The radiosurgical results of treating patients with AVMs before the MR imaging era are thought to reflect the limitations of twodimensional evaluation of AVM nidi. 10 Precise identification of AVM nidi will produce better obliteration rates and fewer complications. Long-term results of performing lower-dose GKS based on three-dimensional imaging studies for AVMs are presented in this report.
Clinical Material and Methods
One hundred fourteen patients treated before May 1996, were followed up for 10 to 15 years after treatment and form the basis for this study. There were 68 male and 46 female patients, ranging in age from 10 to 68 years (mean 35.4 years). Intravascular embolization was performed in 21 patients, and 14 patients underwent surgical removal of their AVM prior to GKS. After angiographic examination, T 1 -weighted and proton density or T 2 -weighted MR images were obtained with a 1-tesla unit. The mean margin dose was 19.5 Gy to the 50% isodose line. Volume staging treatment for large AVMs was performed at 3-to 6-month intervals. Follow-up studies were usually performed by physicians at the original referring hospitals; annual or biennial angiograms were obtained until total obliteration could be confirmed or until the patient refused to undergo further examinations. Repeated GKS was planned when apparent residual nidi were demonstrated on angiography 2 to 3 years after treatment. Magnetic resonance imaging studies were indicated when patients experienced clinical symptoms or desired an outpatient examination (or refused to undergo angiography). Patients without an ongoing relationship with their referring physicians were interviewed by telephone.
An optimal radiation dose (Յ 20-Gy margin dose ) was administered, which depended on the location, volume, and type of AVM. 3 Those AVMs located in eloquent areas such as the motor cortex, internal capsule, and brainstem were treated with an even lower dose (Յ 18 Gy). Large AVMs (Ͼ 15 ml) were treated in a compartmentalized fashion or in stages (volume or dose) by using a margin dose of up to 20 Gy. Large, slow-flow AVMs were treated with a margin dose of 18 Gy. Nidus identification during GKS was performed using both serial subtraction angiography and MR imaging. Potential MR image distortion was assessed with coregistration of CT scans in all patients treated in the same period and later confirmed with angiography. Patients in whom metal clips or wire had been placed during surgery underwent thin-section, enhanced CT scanning instead of MR imaging. Surrounding brain parenchyma as well as large draining veins were excluded from the treatment isodose line (Fig. 1) . Table 1 . Most AVMs were located deep in the brain or in eloquent areas. Angiographic examination was performed in 76 patients and total AVM obliteration was demonstrated in 65 (85.5%) of them (Fig. 2) . The AVM volumes and obliteration rates are shown in Table 2 . The obliteration rate was closely related to the AVM volume. Eleven patients underwent repeated GKS, which included staged treatment, and total AVM obliteration was demonstrated in six. Most of 29 patients without angiography and with smallvolume AVMs (lesions Յ 10 ml) have rates of obliteration similar to those in patients with angiography. Magnetic resonance imaging studies were performed in these patients but it was difficult to evaluate the degree of obliteration, especially in patients with previous hemorrhagic episodes. The AVM locations and obliteration rates are shown in Table 3 . The obliteration rate was similar but somewhat lower in patients with deep-seated AVMs. Of 29 patients in whom follow-up angiography was not performed, 19 described themselves as healthy; 10 were lost to follow up.
Results

The locations of the AVMs are listed in
Symptomatic deterioration occurred in 12 patients (Table 4) . Nine patients experienced bleeding during the latency period (0.7%/year) and four of them suffered lethal hemorrhage. No deaths occurred in patients who underwent embolization prior to GKS. Symptomatic early complications were extensive brain edema after a second GKS in one patient (Fig. 3) and an ARE on the internal capsule in one. Delayed cyst formation was found in one patient as a late complication 10 years after treatment (Fig. 4) . No treatment-related death has been noted to date. Discussion Gamma Knife surgery is a safe and effective treatment for AVMs in the brain, especially for those that are deep seated or situated in eloquent areas, such as motor, speech, and visual cortices. Several AREs have been reported as early and late complications after treatment: brain swelling (edema), necrosis, arterial stenosis, cyst formation, encapsulated hematoma, and hemorrhage after nidus obliteration. 1, [6] [7] [8] 11 The cause of these AREs on the surrounding white matter seems to be damage to oligodendrocytes following reactions of other glial cells such as microglia and astrocytes, which may be related to brain edema, necrosis, and delayed cyst formation. Adverse radiation effects on arteries seem to involve damage to endothelial cells followed by reactions of the microscopic and macroscopic vascular wall, which may cause arterial stenosis, encapsulated hematoma, and hemorrhage after nidus obliteration. 4 High doses of radiation to the surrounding brain may increase the incidence of these AREs.
Although the treatment dose is related to the obliteration rate, high doses are not recommended for larger AVMs. The concept of optimal dose treatment is based on a balance between obliteration and complication rates. In this series, a lower dose (Յ 20 Gy) has produced a satisfactory AVM obliteration rate, and the complication rate has been very low during the 10-to 15-year followup period post-GKS. Lower-dose GKS seems to be adequate for the treatment of small AVMs. Long-term results in patients who underwent low-dose treatment for large vestibular schwannomas have shown not only very low complication rates but also functional preservation of cranial nerves. 2 Optimal dosing depending on the volume, location, and flow-type of the AVM 3 should be considered as a viable treatment, especially for those AVMs located in and around the internal capsule.
Before the MR imaging era, nidus evaluation during radiosurgery was performed using only angiography. Because angiography does not demonstrate the surrounding brain tissue, the tissue might inadvertently be included in treatment isodose line or the nidus might not be covered completely in the prescribed isodose. Although there is a tendency toward higher obliteration rates in small AVMs treated with the classic higher dose of 25 Gy, there is also increased risk of AREs to the surrounding brain. In larger AVMs treated with the classic higher dose, the obliteration rate is lower and the complication rate is higher compared with the lower-dose treatment. Precise evaluation of the nidus is important to decrease the possibility of the patient having to undergo repeated GKS because of residual nidi after the first treatment. 9 The data derived from the relationship between the dose and the obliteration rate should be reevaluated, and those data obtained in patients treated before the MR imaging era should be excluded. Magnetic resonance image distortion was not negligible in the 1990s, and stereotactic procedures were performed based on MR images. The extent of distortion was variable depending on the MR unit used. All MR images used for treatment planning in this series were coregistered with CT scans in patients with tumors treated in the same period. The problems associated with MR image distortion were ameliorated by using image fusion software (Gamma Plan; Elekta Instrument AB, Stockholm, Sweden).
Newer MR units produce images that are more suitable for use in stereotactic procedures. Treatment results in the long-term follow-up period may still be subject to the influence of MR image distortion, especially when the MR imaging studies have not been fused with CT studies to verify their accuracy. Identification of the internal capsule is important in patients with AVMs located in and around the thalamus and basal ganglia to avoid complications or AREs. Image shift or distortion even when using newer MR units, such as those that produce functional and metabolic images, is still possible. Further refinement of radiosurgical treatment for patients with AVMs will be expected based on advances in multimodality imaging with three-dimensional angiography, CT angiography, enhanced MR angiography, and functional mapping techniques.
Conclusions
Based on findings on angiography and MR imaging studies, AVM obliteration was achieved in 71 of 76 patients after repeated lower-dose GKS. Symptomatic complications occurred in three of 104 patients during a follow-up period of up to 15 years. Lower-dose GKS is an effective and safe treatment for patients with AVMs located in functional areas, and lower-dose GKS may decrease the long-term AREs to the surrounding brain.
